Compounds > kainic acid
Page last updated: 2024-08-21

kainic acid and Parkinson Disease

kainic acid has been researched along with Parkinson Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Emam, A; Al-Shraim, M; Moldzio, R; Radad, K; Rausch, WD1
Göltl, P; Hafenscher, F; Miklya, I; Pencz, N1
Bianchi, L; Bolam, JP; Della Corte, L; Galeffi, F1
Jonsson, G1
McLennan, H1
Hefti, F; Liebman, J; Melamed, E; Pettibone, DJ; Wurtman, RJ1
Klockgether, T; Turski, L1
Ball, EF; Ince, PG; Johnson, M; Shaw, PJ1
Bianchi, L; Corte, LD; Hayes, J; Tipton, KF1
Kargieman, L; Kasanetz, F; Murer, MG; Pazo, JH; Riquelme, LA; Tseng, KY1

Reviews

2 review(s) available for kainic acid and Parkinson Disease

ArticleYear
[The role of parkin in Parkinson's disease].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2014, Volume: 16, Issue:2

    Topics: alpha-Synuclein; Animals; Dopamine; Dopaminergic Neurons; Gene-Environment Interaction; Humans; Intracellular Signaling Peptides and Proteins; Kainic Acid; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mitochondria; Oncogene Proteins; Oxidative Stress; Parkinson Disease; Point Mutation; Proteasome Endopeptidase Complex; Protein Deglycase DJ-1; Protein Kinases; Protein Serine-Threonine Kinases; Ubiquitin; Ubiquitin-Protein Ligases

2014
Chemical neurotoxins as denervation tools in neurobiology.
    Annual review of neuroscience, 1980, Volume: 3

    Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Animals; Benzylamines; Brain; Catecholamines; Denervation; Dopamine; Glutamates; Humans; Hydroxydopamines; Ibotenic Acid; Kainic Acid; Neurotoxins; Neurotransmitter Agents; p-Chloroamphetamine; Parkinson Disease; Rats; Receptors, Neurotransmitter; Schizophrenia; Serotonin

1980

Other Studies

8 other study(ies) available for kainic acid and Parkinson Disease

ArticleYear
Neurotoxic effects of domoic acid on dopaminergic neurons in primary mesencephalic cell culture.
    Folia neuropathologica, 2018, Volume: 56, Issue:1

    Topics: Animals; Cells, Cultured; Dopaminergic Neurons; Kainic Acid; Neuromuscular Depolarizing Agents; Parkinson Disease

2018
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.
    The European journal of neuroscience, 2003, Volume: 18, Issue:4

    Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Basal Ganglia; Chromatography, High Pressure Liquid; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Injections, Intraventricular; Kainic Acid; Male; Microdialysis; Models, Animal; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase

2003
Excitatory amino acid receptors.
    Progress in clinical and biological research, 1981, Volume: 68

    Topics: Animals; Aspartic Acid; Binding Sites; Brain; Glutamates; Glutamic Acid; Humans; Kainic Acid; Kinetics; Neurons; Parkinson Disease; Protein Conformation; Receptors, Cell Surface; Receptors, Glutamate; Receptors, Neurotransmitter; Spinal Cord

1981
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
    Neurology, 1981, Volume: 31, Issue:6

    Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain Diseases; Corpus Striatum; Dopamine; Glutamate Decarboxylase; Kainic Acid; Levodopa; Male; Neurons; Parkinson Disease; Rats; Serotonin

1981
Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia.
    Annals of neurology, 1993, Volume: 34, Issue:4

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Basal Ganglia; Cycloleucine; Electromyography; Glutamates; Glutamic Acid; Kainic Acid; Male; Muscles; N-Methylaspartate; Parkinson Disease; Rats; Receptors, Glutamate

1993
The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Brain research, 1994, Sep-26, Volume: 658, Issue:1-2

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Autoradiography; Basal Ganglia; Binding Sites; Dizocilpine Maleate; Female; Glycine; Humans; Kainic Acid; Male; Mesencephalon; Parkinson Disease; Radioligand Assay; Receptors, Glycine; Receptors, Metabotropic Glutamate; Reference Values; Strychnine; Tritium

1994
Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine.
    Brain research bulletin, 2001, May-15, Volume: 55, Issue:2

    Topics: Aconitate Hydratase; Adrenergic Agents; Animals; Dopamine; Extracellular Space; gamma-Aminobutyric Acid; Globus Pallidus; Iron; Kainic Acid; Male; Microdialysis; Neostriatum; Neural Pathways; Neurons; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Oxidopamine; Parkinson Disease; Presynaptic Terminals; Rats; Rats, Wistar; Substantia Nigra; Sulfhydryl Compounds; Taurine

2001
Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Brain research, 2001, Jun-15, Volume: 904, Issue:1

    Topics: Action Potentials; Animals; Biological Clocks; Disease Models, Animal; Excitatory Amino Acid Agonists; Kainic Acid; Male; Nerve Degeneration; Neural Pathways; Neurons; Neurotoxins; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Subthalamic Nucleus; Sympatholytics

2001